COSCIENS Biopharma Inc. (TSX: CSCI)
Health Care · Biotechnology · CA
CA$7.50
+3.59% today · -42.5% 1Y
COSCIENS Biopharma Inc. (TSX: CSCI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.22M and employs 28 people.
Over the last twelve months the share price has lost 42.5%, trading between 3.30 and 14.80.
Tweenvest scores COSCIENS Biopharma Inc. across four factors: quality 45/100, value 63/100, growth 94/100. Its strongest factor is growth.
CSCI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.22M
- Revenue (TTM)
- $8.72M
- P/E
- —
- EPS
- 6.22
- Dividend yield
- —
- Beta (5Y)
- 1.89
- 52-week high
- CA$14.80
- 52-week low
- CA$3.30
- Avg volume (3M)
- —
- Shares outstanding
- 996.39K
- Employees
- 28
- Next earnings
- —
About COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
- ISIN
- CA22112H2000
- Founded
- 1990
- Listed since
- Sep 18, 1996
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.